Vanderbilt University Medical Center: Data Haul Improves Immunotherapy Response Prediction
January 17, 2024
January 17, 2024
NASHVILLE, Tennessee, Jan. 17 (TNSres) -- Vanderbilt University Medical Center issued the following news:
By Paul Govern
A subset of cancer patients will respond well to immune checkpoint inhibitor (ICI) treatment, others not at all. As predictive biomarkers for ICI response are proposed, often they fail to replicate in later studies or generalize to different cancer types.
Seeking to address this impasse with greater statistical power, biostatisticians at . . .
By Paul Govern
A subset of cancer patients will respond well to immune checkpoint inhibitor (ICI) treatment, others not at all. As predictive biomarkers for ICI response are proposed, often they fail to replicate in later studies or generalize to different cancer types.
Seeking to address this impasse with greater statistical power, biostatisticians at . . .